About liraglutid e
Glucagon-like peptide-1 receptor agonist
Used for
- Long-term weight management alongside reduced-calorie eating and increased physical activity.
- Weight management in adults with obesity or overweight and related health conditions.
- Weight management in eligible children aged 12 years or older with obesity.
Usual adult dose
Inject under the skin once daily. Start at 0.6 mg daily; increase weekly to 3 mg daily as tolerated.
Usual dose in children
For eligible children aged 12 years or older: start at 0.6 mg under the skin daily; increase weekly to 3 mg daily as tolerated.
Common side effects
- Nausea, vomiting, diarrhea, constipation, or abdominal pain.
- Headache, dizziness, or tiredness.
- Injection-site reactions.
- Low blood sugar, especially with insulin or certain diabetes medicines.
Important warnings
- Seek urgent care for severe, persistent abdominal pain, which may indicate pancreatitis.
- May increase gallstone or gallbladder inflammation risk.
- Not for use with another liraglutide product or another GLP-1 medicine.
- Avoid with personal or family history of medullary thyroid cancer or MEN 2.
Pregnancy
Do not use for weight loss during pregnancy; discontinue if pregnancy occurs.
Breastfeeding
Not recommended while breastfeeding; discuss suitable treatment with a healthcare professional.
Interactions
- Insulin or sulfonylureas may increase low blood sugar risk.
- Slows stomach emptying and may affect absorption of oral medicines.
- Other liraglutide products or GLP-1 medicines should not be combined.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.